Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neonatal Perinatal Med ; 17(2): 261-264, 2024.
Article in English | MEDLINE | ID: mdl-38640175

ABSTRACT

 Cyanosis is a bluish discoloration of the tissues due to increased levels of deoxygenated hemoglobin in capillaries. It is a common finding in newborn infants that can be caused by different diseases, including pulmonary, cardiac, infectious, and hematological disorders. Methemoglobinemia is a rare cause of cyanosis, in which hemoglobin is oxidized, changing its heme iron configuration from the ferrous (Fe2 +) to the ferric (Fe3 +) state, creating methemoglobin (Met-Hb), a form that does not bind oxygen, leading to decreased oxygen delivery to the tissues and cyanosis. We report a rare case of a preterm newborn, who developed cyanosis and worsening hypoxemia on day ten of life, she was found to have elevated Met-Hb percentage in blood gas analysis that required treatment with intravenous methylene blue. Her symptoms resolved after a period of maintenance treatment with oral methylene blue and ascorbic acid, and the etiology of her disease remains unclear.


Subject(s)
Ascorbic Acid , Cyanosis , Infant, Premature , Methemoglobinemia , Methylene Blue , Humans , Methemoglobinemia/diagnosis , Methemoglobinemia/etiology , Infant, Newborn , Female , Methylene Blue/therapeutic use , Cyanosis/etiology , Ascorbic Acid/therapeutic use , Ascorbic Acid/administration & dosage , Blood Gas Analysis , Hypoxia/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...